Torre F Della, Limonta A, Molinari A, Masala E, Vercelloni S, Torre E Della
I.N.R.C.A.--IRCCS, Pneumologic Department, Chief dott. E. Marchi, Casatenovo, LC, Italy.
Eur Ann Allergy Clin Immunol. 2007 Jan;39(1):9-11.
We have noted several patients suffering for rhinitis and/or asthma symptoms in the summer months without positive skin tests for pollens blossoming in the corresponding season. So we tried to determine the pollination pattern of pollens usually not tested, because no company produces the corrisponding extract.
We determined airborne pollination by means of a volumetric pollen trap for five years from 2001 to 2005.
We found, in addition to well-known aeroallergens, a significant percentage of Cannabaceae from the end of July to mid September with the highest concentration in 2004 (140 gr/m3).
The potential allergenicity of Cannabis pollen was supported in the United States, where they found some patients with rhinitis or asthma during the pollen seasons and positive prick test for Cannabis, but the clinical significance of Cannabaceae pollen as an aeroallergen in Europe is still undefined.
我们注意到有几位患者在夏季出现鼻炎和/或哮喘症状,但对应季节开花花粉的皮肤试验呈阴性。由于没有公司生产相应提取物,所以我们试图确定通常未检测花粉的授粉模式。
我们在2001年至2005年期间,通过容积式花粉捕集器对空气中的花粉授粉情况进行了五年的测定。
我们发现,除了常见的空气变应原外,从7月底到9月中旬有相当比例的大麻科花粉,2004年浓度最高(140粒/立方米)。
在美国,大麻花粉的潜在致敏性得到了证实,在那里他们发现一些患者在花粉季节出现鼻炎或哮喘,且大麻点刺试验呈阳性,但大麻科花粉作为欧洲空气变应原的临床意义仍不明确。